Showing 7441-7450 of 10620 results for "".
- Idiopathic Pulmonary Fibrosis: Exploring a Potential New Treatment Pathwayhttps://reachmd.com/news/idiopathic-pulmonary-fibrosis-exploring-a-potential-new-treatment-pathway/2474291/For decades, idiopathic pulmonary fibrosis (IPF) has loomed as one of pulmonary medicine’s most daunting challenges—a chronic, progressive lung disease marked by relentless scarring of the lungs, leading to irreversible respiratory failure. But new research from Tul
- Empowering Pain Relief: How Central European Patients Are Reframing Endometriosis Care Through Self-Managementhttps://reachmd.com/news/self-management-in-endometriosis-pain-analysis-from-a-cross-sectional-survey-in-central-europe/2474216/Amid the rising prevalence of endometriosis across Europe, a new cross-sectional survey from Germany, Austria, and Switzerland reveals a shift in how patients are managing their pain—by taking health into their own hands. The findings underscore a growing trend: pa
- AI in Thyroid Cancer Diagnosis: Evaluating Accuracy and Risk Classificationhttps://reachmd.com/news/ai-in-thyroid-cancer-diagnosis-evaluating-accuracy-and-risk-classification/2474302/Clinical studies indicate that an AI model can classify thyroid cancer stages and risk levels with accuracy exceeding 90%, setting the stage for more precise and efficient diagnostic strategies. Overview of Key Discoveries In a landmark
- Lung Transplant Outcomes: Tacrolimus vs. Cyclosporine in Preventing CLADhttps://reachmd.com/news/lung-transplant-outcomes-tacrolimus-vs-cyclosporine-in-preventing-clad/2474285/For lung transplant recipients, chronic lung allograft dysfunction (CLAD) remains a looming adversary—an insidious condition that gradually undermines graft function and compromises long-term survival. While the medical community has made strides in under
- Inflammation and Cardiovascular Health: The Role of Myeloperoxidase Inhibition in Obesityhttps://reachmd.com/news/inflammation-and-cardiovascular-health-the-role-of-myeloperoxidase-inhibition-in-obesity/2474299/Recent research underscores that elevated levels of myeloperoxidase (MPO) in individuals with obesity are associated with impaired vascular function, highlighting that targeting this enzyme could offer a strategic approach to reducing inflammation and
- Targeting GlycoRNAs in Cancer: Emerging Therapeutic Approacheshttps://reachmd.com/news/targeting-glycornas-in-cancer-emerging-therapeutic-approaches/2474298/Advancements in oncology have discovered that cell surface glycoRNAs associate with RNA-binding proteins, forming distinctive complexes that create new epitopes. These epitopes crucially impact cell signaling, survival, and metastasis.
- Combined Hind-Foot Alignment and Medial Arch Reconstruction in Pediatric Flexible Flatfoothttps://reachmd.com/news/combined-hind-foot-alignment-and-medial-arch-reconstruction-in-pediatric-flexible-flatfoot/2474249/In the realm of pediatric orthopedic surgery, a novel dual-intervention technique is showing promise for one of the most common—and often stubborn—foot conditions in children: flexible flatfoot. Drawing from recent case-series analyses, surgeons are now merging hind-
- Renal Clues at Diagnosis: Uncovering Kidney Risk in New-Onset Diabeteshttps://reachmd.com/news/renal-health-and-guideline-compliance-in-newly-diagnosed-diabetes-mellitus/2474259/When patients are first diagnosed with diabetes mellitus, the clinical lens often zooms in on blood glucose control. But a growing body of evidence suggests another vital parameter deserves early attention: renal health. Research now points to a high prevalence of
- The Role of 3D Gene Architecture in Glioblastomahttps://reachmd.com/news/the-role-of-3d-gene-architecture-in-glioblastoma/2474273/This article investigates the association between the three-dimensional folding of DNA within brain cells and glioblastoma. Leveraging preclinical research from Weill Cornell Medicine, it examines the impact of disruptions in 3D gene hubs on cellular functions.
- Clinical Data on Lumenis’ New Laser Hair Removal Solution to Be Presented at ASLMS Conferencehttps://reachmd.com/news/new-data-on-lumenis-new-laser-hair-removal-solution-to-be-presented-at-aslms-conference/2475349/Lumenis Be. Ltd. unveiled the newest edition of its breakthrough dual-wavelength laser hair removal solution, SPLENDOR XTM ahead of the American Society for Laser Medicine and Surgery (ASLMS) Conference. SPLENDOR XTM is powered by Lumenis’ proprietary BLEND X® tec